Xeris Pharmaceuticals Announces Exercise of Underwriters’ Option to Purchase Additional Shares
CHICAGO–(BUSINESS WIRE)–Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use…